{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:25:49Z","timestamp":1790429149711,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Rouen University Hospital"},{"name":"French National Health Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1093\/jac\/dky271","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T19:13:19Z","timestamp":1529953999000},"page":"2716-2720","source":"Crossref","is-referenced-by-count":20,"title":["Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir"],"prefix":"10.1093","volume":"73","author":[{"given":"Elodie","family":"Alessandri-Gradt","sequence":"first","affiliation":[{"name":"Normandie Univ, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Charpentier","sequence":"additional","affiliation":[{"name":"IAME, UMR 1137, INSERM, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, AP-HP, Laboratoire de Virologie, H\u00f4pital Bichat, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Leoz","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mourez","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Descamps","sequence":"additional","affiliation":[{"name":"IAME, UMR 1137, INSERM, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, AP-HP, Laboratoire de Virologie, H\u00f4pital Bichat, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6417-4083","authenticated-orcid":false,"given":"Jean-Christophe","family":"Plantier","sequence":"additional","affiliation":[{"name":"Normandie Univ, UNIROUEN, EA2656, GRAM, CHU de Rouen, Laboratoire de Virologie associ\u00e9 au CNR du VIH, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,18]]},"reference":[{"key":"key\n\t\t\t\t20180921035207_dky271-B1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/CMR.00012-13","article-title":"Non-M variants of human immunodeficiency virus type 1","volume":"26","author":"Mourez","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180921035207_dky271-B2","doi-asserted-by":"crossref","first-page":"e1005029.","DOI":"10.1371\/journal.ppat.1005029","article-title":"The two-phase emergence of non pandemic HIV-1 group O in Cameroon","volume":"11","author":"Leoz","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180921035207_dky271-B3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/jac\/dkx190","article-title":"HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors","volume":"72","author":"Alessandri-Gradt","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/aid.2012.0375","article-title":"HIV type-1 group O infection in Gabon: low prevalence rate but circulation of genetically diverse and drug-resistant HIV type-1 group O strains","volume":"29","author":"Li\u00e9geois","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180921035207_dky271-B5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/QAI.0b013e318201a904","article-title":"Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M","volume":"56","author":"Depatureaux","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180921035207_dky271-B6","doi-asserted-by":"crossref","first-page":"8893","DOI":"10.1128\/JVI.71.11.8893-8898.1997","article-title":"Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses","volume":"71","author":"Descamps","year":"1997","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180921035207_dky271-B7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/prot.24726","article-title":"Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action","volume":"83","author":"Langley","year":"2015","journal-title":"Proteins"},{"key":"key\n\t\t\t\t20180921035207_dky271-B8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/infdis\/jis432","article-title":"Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects","volume":"206","author":"Nettles","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180921035207_dky271-B9","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.1016\/S2352-3018(15)00177-0","article-title":"Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial","volume":"2","author":"Lalezari","year":"2015","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20180921035207_dky271-B10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3851\/IMP3112","article-title":"Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trial","volume":"22","author":"Thompson","year":"2017","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180921035207_dky271-B11","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.00426-12","article-title":"In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068","volume":"56","author":"Nowicka-Sans","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dkt412","article-title":"Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068","volume":"69","author":"Zhou","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/QAI.0b013e31829726f3","article-title":"Prediction of virological response and assessment of resistance emergence to the HIV-1 attachment inhibitor BMS-626529 during 8-day monotherapy with its prodrug BMS-663068","volume":"64","author":"Ray","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180921035207_dky271-B14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/QAI.0000000000001602","article-title":"Viral drug resistance through 48 weeks, in a phase 2b, randomized, controlled trial of the HIV-1 attachment inhibitor prodrug, fostemsavir","volume":"77","author":"Lataillade","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180921035207_dky271-B15","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/molbev\/mst197","article-title":"MEGA6: Molecular Evolutionary Genetics Analysis version 6.0","volume":"30","author":"Tamura","year":"2013","journal-title":"Mol Biol Evol"},{"key":"key\n\t\t\t\t20180921035207_dky271-B16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jac\/dks067","article-title":"Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 \u2018non-B\u2019-infected patients","volume":"67","author":"Charpentier","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.01173-10","article-title":"In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043","volume":"55","author":"Zhou","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jac\/dku360","article-title":"Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes","volume":"70","author":"Fofana","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180921035207_dky271-B19","author":"Kozal"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/10\/2716\/25770303\/dky271.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T08:13:51Z","timestamp":1604477631000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/10\/2716\/5055849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,18]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,7,18]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky271","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,7,18]]}}}